# Thoratec Corporation HeartMate PHP™ Cardiogenic Shock Trial

> **NCT02279979** · NA · TERMINATED · sponsor: **Abbott Medical Devices** · enrollment: 9 (actual)

## Conditions studied

- Cardiogenic Shock

## Interventions

- **DEVICE:** HeartMate PHP

## Key facts

- **NCT ID:** NCT02279979
- **Lead sponsor:** Abbott Medical Devices
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-10
- **Primary completion:** 2017-01
- **Final completion:** 2017-01
- **Target enrollment:** 9 (ACTUAL)
- **Last updated:** 2023-07-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02279979

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02279979, "Thoratec Corporation HeartMate PHP™ Cardiogenic Shock Trial". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT02279979. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*